Acadia Pharmaceuticals (ACAD) Return on Sales [ROS] (2010 - 2026)
Acadia Pharmaceuticals' Return on Sales [ROS] was 12.29% in Q2 2026, up 0.05 percentage points from 12.24% a year earlier and up 14.01 percentage points from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Acadia Pharmaceuticals' Return on Sales [ROS] was 7.59% through Jun 30, 2026, down 15.66 percentage points year-over-year; for FY2025, it was 9.78%, down 14.31 percentage points from FY2024.
- Return on Sales [ROS] shows a five-year change of +74.66 percentage points (FY2020 to FY2025).
- In earlier years, Return on Sales [ROS] was 24.10% in FY2024 (+34.20 pp), -10.10% in FY2023 (+33.13 pp), -43.23% in FY2022 (-8.02 pp) and -35.20% in FY2021 (+29.67 pp).
- Quarterly Return on Sales [ROS] has moved between -97.88% (Q1 2022) and 59.13% (Q4 2024) over five years.
- Compared with a year earlier, Return on Sales [ROS] was higher in five of the last eight quarters, with an average year-over-year change of +2.71 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q3 2021 (a gain of 59.61 percentage points); the worst was Q4 2025 (a drop of 53.01 percentage points).
- Per Business Quant data, ACAD's Return on Sales [ROS] in the three quarters before Q2 2026 was -1.72% (Q1 2026), 6.12% (Q4 2025) and 12.83% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 28.37% |
| 10 | Acadia Pharmaceuticals | 3.50 Bn | 21.37 Mn | 279.64 Mn | 12.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.29% |
| Mar 31, 2026 | -1.72% |
| Dec 31, 2025 | 6.12% |
| Sep 30, 2025 | 12.83% |
| Jun 30, 2025 | 12.24% |
| Mar 31, 2025 | 7.90% |
| Dec 31, 2024 | 59.13% |
| Sep 30, 2024 | 12.64% |
| Jun 30, 2024 | 12.58% |
| Mar 31, 2024 | 7.39% |
| Dec 31, 2023 | 15.12% |
| Sep 30, 2023 | -27.29% |
| Jun 30, 2023 | 1.84% |
| Mar 31, 2023 | -45.23% |
| Dec 31, 2022 | -33.75% |
| Sep 30, 2022 | -23.61% |
| Jun 30, 2022 | -25.01% |
| Mar 31, 2022 | -97.88% |
| Dec 31, 2021 | -34.15% |
| Sep 30, 2021 | -11.63% |
API Access
Acadia Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();